Related Experiment Video

Updated: May 13, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Cancer cells acquire resistance to anticancer drugs: an update

Hsing-Pang Lu1, Chuck C K Chao

  • 1Department of Biochemistry and Molecular Biology, and Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Biomedical Journal
|February 28, 2013
PubMed

Insights

Identifying genes involved in cancer drug resistance is crucial for improving chemotherapy. New cisplatin resistance (CPR) genes were found to reduce chemoresistance and tumor growth, offering potential new therapies.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Chemotherapy efficacy is frequently limited by the development of drug-resistant cancer cells.
  • While mechanisms of chemoresistance are studied, the specific genes involved remain largely unidentified.
  • Genetic mutations, epigenetic alterations, and alternative splicing are implicated in cancer cell resistance.

Purpose of the Study:

  • To identify novel genes associated with chemoresistance, particularly to cisplatin.
  • To investigate the therapeutic potential of targeting identified chemoresistance genes.

Main Methods:

  • Genomic DNA microarrays were employed to screen for genes linked to cisplatin resistance.
  • Quantitative RT-PCR was used for gene validation.
  • The functional role of identified genes was assessed through gene knockdown experiments in mice models.

Main Results:

  • Several cisplatin resistance (CPR) genes were identified.
  • Knockdown of these CPR genes significantly reduced chemoresistance in cancer cells.
  • Suppression of tumor xenograft growth was observed in cisplatin-treated mice following CPR gene knockdown.

Conclusions:

  • The identified CPR genes are critical mediators of cisplatin resistance.
  • Targeting these CPR genes presents a promising therapeutic strategy to overcome chemoresistance.
  • These findings may lead to improved efficacy of anticancer drugs and better patient outcomes.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...